Aspire Private Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$400K Sell
8,644
-127
-1% -$5.88K 0.09% 141
2025
Q1
$535K Buy
8,771
+1,129
+15% +$68.9K 0.13% 124
2024
Q4
$432K Buy
7,642
+1,504
+25% +$85.1K 0.11% 124
2024
Q3
$318K Buy
6,138
+1,008
+20% +$52.2K 0.08% 133
2024
Q2
$213K Sell
5,130
-9,207
-64% -$382K 0.05% 149
2024
Q1
$778K Buy
14,337
+3,141
+28% +$170K 0.2% 86
2023
Q4
$575K Buy
11,196
+7,812
+231% +$401K 0.17% 93
2023
Q3
$196K Sell
3,384
-8,195
-71% -$476K 0.06% 127
2023
Q2
$740K Buy
11,579
+913
+9% +$58.4K 0.24% 61
2023
Q1
$739K Buy
10,666
+956
+10% +$66.3K 0.25% 57
2022
Q4
$699K Buy
9,710
+1,704
+21% +$123K 0.25% 56
2022
Q3
$569K Buy
8,006
+7,844
+4,842% +$557K 0.22% 60
2022
Q2
$12K Buy
162
+41
+34% +$3.04K ﹤0.01% 320
2022
Q1
$9K Sell
121
-89
-42% -$6.62K ﹤0.01% 345
2021
Q4
$13K Sell
210
-20
-9% -$1.24K ﹤0.01% 317
2021
Q3
$14K Sell
230
-8,077
-97% -$492K ﹤0.01% 288
2021
Q2
$555K Buy
8,307
+2,439
+42% +$163K 0.18% 74
2021
Q1
$370K Buy
5,868
+192
+3% +$12.1K 0.13% 84
2020
Q4
$352K Sell
5,676
-77
-1% -$4.78K 0.13% 87
2020
Q3
$347K Buy
5,753
+1,509
+36% +$91K 0.14% 84
2020
Q2
$250K Buy
4,244
+2,442
+136% +$144K 0.12% 85
2020
Q1
$100K Sell
1,802
-159
-8% -$8.82K 0.05% 116
2019
Q4
$126K Buy
1,961
+49
+3% +$3.15K 0.05% 144
2019
Q3
$97K Buy
1,912
+206
+12% +$10.5K 0.05% 162
2019
Q2
$77K Buy
1,706
+291
+21% +$13.1K 0.04% 173
2019
Q1
$68K Sell
1,415
-1,664
-54% -$80K 0.03% 209
2018
Q4
$160K Buy
+3,079
New +$160K 0.09% 123